Full-Time
Updated on 8/12/2026
Calibration services and test equipment distributor
No salary listed
Oak Ridge, TN, USA
In Person
Travel may be required for up to 25% of the work schedule.
Associate's
See people who can refer or advise you
Transcat provides calibration services and distributes test and measurement equipment across North America. It began as a tool manufacturer, then became a distributor, and later focused on high-value services by opening calibration labs to ensure instruments meet precise standards. Their products and services work by calibrating instruments in trusted labs to national or industry standards, offering traceable, documented calibration results and related support. The company differentiates itself through a nationwide service network and growth via strategic acquisitions, expanding its geographic reach and technical capabilities in tightly regulated sectors such as life sciences, aerospace, and energy. Its goal is to help customers maintain accurate, compliant measurement tools and equipment, enabling reliable operations in highly regulated industries.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Town of Ogden, New York
Founded
1964
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Tuition Reimbursement
Employee Stock Purchase Plan
Paid Vacation
Flexible Work Hours
Training Programs
Transcat Inc reported strong fiscal Q1 2027 results, with consolidated revenue rising 22% to $92.9 million, driven by double-digit growth in both segments. Service revenue grew 27% year-over-year, including 13% organic growth — marking the 69th consecutive quarter of service revenue expansion. Service gross profit increased 31%, with margins expanding 90 basis points due to operational leverage and maturing customer relationships. The company's recent acquisition of SCM Metrology and Laboratories is progressing well, expanding its Central America presence. However, diluted earnings per share fell to $0.14, impacted by increased intangible asset amortisation, stock-based compensation, interest expense, and executive transition costs. Distribution segment gross margins decreased 380 basis points to 31.4% due to unusually high prior-year vendor rebates. Management expressed confidence in achieving high single-digit service organic growth for the full fiscal year, citing strong demand across life sciences, aerospace, and defence sectors.
Transcat reported second quarter 2026 results that exceeded revenue expectations, with sales reaching $92.95 million, up 21.6% year-on-year and 7.4% above analyst estimates of $86.55 million. The measurement equipment distributor posted non-GAAP earnings of $0.51 per share, beating consensus estimates of $0.38 by 35.1%. Adjusted EBITDA came in at $14 million, surpassing analyst expectations of $12.46 million by 12.4%, representing a 15.1% margin. Free cash flow improved to $4.84 million from negative $975,000 in the same quarter last year. However, operating margin declined to 4% from 7.1% in the prior-year quarter. Analysts forecast revenue growth of 6% over the next 12 months, a slowdown from the company's recent 14.5% two-year growth rate.
Transcat (NASDAQ:TRNS) releases earnings results, beats expectations by $0.13 EPS. August 4, 2026 Key points. * Transcat beat quarterly expectations: The company reported earnings of $0.51 per share, $0.13 above consensus, while revenue reached $92.95 million versus estimates of $86.55 million. * Shares rose to $91.89 during Tuesday trading, near the company's 12-month high of $95.22. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $105.50. * Institutional investors own 98.34% of Transcat's stock, with several funds recently initiating or increasing positions. * MarketBeat previews the top five stocks to own by September 1st. Transcat (NASDAQ:TRNS - Get Free Report) announced its quarterly earnings data on Tuesday. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13, FiscalAI reports. Transcat had a return on equity of 5.84% and a net margin of 1.62%.The business had revenue of $92.95 million during the quarter, compared to analyst estimates of $86.55 million. Transcat price performance. Transcat stock traded up $2.31 during trading hours on Tuesday, hitting $91.89. 119,663 shares of the stock were exchanged, compared to its average volume of 150,163. The stock has a market capitalization of $860.09 million, a P/E ratio of 158.43 and a beta of 0.68. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.99 and a current ratio of 2.33. Transcat has a 12 month low of $50.23 and a 12 month high of $95.22. The business's 50-day moving average is $88.54 and its two-hundred day moving average is $78.89. Analyst Ratings changes. A number of analysts have issued reports on the stock. Zacks Research upgraded shares of Transcat from a "strong sell" rating to a "hold" rating in a research note on Friday, May 15th. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. Finally, Weiss Ratings raised Transcat from a "sell (d)" rating to a "sell (d+)" rating in a research report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $105.50. Institutional trading of Transcat. Institutional investors and hedge funds have recently modified their holdings of the stock. Lazard Asset Management LLC acquired a new stake in Transcat during the 2nd quarter valued at $54,000. Tower Research Capital LLC TRC boosted its position in Transcat by 245.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company's stock worth $97,000 after buying an additional 798 shares during the period. Marshall Wace LLP acquired a new stake in Transcat in the fourth quarter valued at $236,000. Balyasny Asset Management L.P. bought a new position in shares of Transcat during the fourth quarter worth about $247,000. Finally, Boothbay Fund Management LLC bought a new position in Transcat during the 3rd quarter worth approximately $368,000. 98.34% of the stock is owned by institutional investors. Transcat company profile. Transcat, Inc NASDAQ: TRNS is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025-accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services. Discover more Business News American Consumer News Cryptocurrency News In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Transcat, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list. While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you'll find 7 stocks that could play a major role in the next tech-driven market boom.
Transcat, a provider of test measurement and calibration services, has appointed Roy Simmons as Chief Strategy and Corporate Development Officer. In this newly created executive role, Simmons will shape the company's enterprise-wide growth strategy, lead M&A activities and align long-term strategy with operations. Simmons brings over 20 years of global leadership experience across strategy, corporate development and operations. He previously served as President of Pear Health Labs and held senior positions at Savant Systems and GE Lighting, where he drove margin expansion and improved cash flow performance. He also led M&A strategy at Life Fitness, including its $490 million sale. The appointment reflects Transcat's commitment to advancing its growth strategy and strengthening its leadership position in the calibration services market.
Transcat reported first-quarter revenue of $89.33 million, up 15.8% year-over-year but slightly below analyst estimates of $89.79 million. The calibration services company's adjusted EPS of $0.56 met expectations, whilst adjusted EBITDA of $14.79 million beat estimates by 6.4%. CEO Jaime Irick attributed growth to strong demand in life sciences, aerospace and energy sectors, plus momentum in high-margin service and rental businesses. However, operating margins declined to 6.1% from 8% in the prior year, partly due to costs from onboarding new customers and technology investments. Management highlighted ongoing integration of recent acquisitions, including SCM Metrology and Laboratories, and expects margin normalisation over the coming year. The company is expanding into energy sector data centres, driving additional rental demand for specialised power equipment.